๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Matrix Metalloproteinase Gene Delivery for Liver Fibrosis

โœ Scribed by Yuji Iimuro; David A. Brenner

Book ID
106493162
Publisher
Springer US
Year
2007
Tongue
English
Weight
540 KB
Volume
25
Category
Article
ISSN
0724-8741

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Matrix metalloproteinase-sensitive therm
Matrix metalloproteinase-sensitive thermogelling polymer for bioresponsive local drug delivery
โœ Vivek Kumar Garripelli; Jin-Ki Kim; Sejin Son; Won Jong Kim; Michael A. Repka; S ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 784 KB

Development of a successful bioresponsive drug delivery system requires exquisite engineering of the materials so that they are able to respond to signals stemming from the physiological environment. In this study we propose a new Pluronic(ยฎ) based thermogelling system containing matrix metalloprote

Difference in gene expression for matrix
Difference in gene expression for matrix metalloproteinase-1 between early and advanced hepatocellular carcinomas
โœ I Okazaki; N Wada; M Nakano; A Saito; K Takasaki; M Doi; K Kameyama; Y Otani; K ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 565 KB

The process of stromal invasion by cancer cells suggests a The histological observation that well-differentiated role of interstitial collagenase (MMP-1) in early HCC, becancer cells in early hepatocellular carcinoma (HCC) incause other MMPs cannot degrade interstitial stroma. The vade portal tracts

Adenoviral delivery of dominant-negative
Adenoviral delivery of dominant-negative transforming growth factor ฮฒ type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats
โœ Ana Marquez-Aguirre; Ana Sandoval-Rodriguez; Jaime Gonzalez-Cuevas; Miriam Bueno ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 574 KB

## Abstract ## Background Dominantโ€negative transforming growth factor ฮฒ type II receptor (TฮฒRIIฮ”cyt) is a protein that blocks transforming growth factor (TGFโ€ฮฒ) signaling. Because the consequences of blocking TGFโ€ฮฒ have not been completely elucidated in liver fibrosis, we analysed the effects of